227 related articles for article (PubMed ID: 16309810)
1. Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study.
Gerra G; Leonardi C; D'Amore A; Strepparola G; Fagetti R; Assi C; Zaimovic A; Lucchini A
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):265-72. PubMed ID: 16309810
[TBL] [Abstract][Full Text] [Related]
2. Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome.
Gerra G; Borella F; Zaimovic A; Moi G; Bussandri M; Bubici C; Bertacca S
Drug Alcohol Depend; 2004 Jul; 75(1):37-45. PubMed ID: 15225887
[TBL] [Abstract][Full Text] [Related]
3. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
[TBL] [Abstract][Full Text] [Related]
4. Experimentally induced aggressiveness in heroin-dependent patients treated with buprenorphine: comparison of patients receiving methadone and healthy subjects.
Gerra G; Zaimovic A; Raggi MA; Moi G; Branchi B; Moroni M; Brambilla F
Psychiatry Res; 2007 Jan; 149(1-3):201-13. PubMed ID: 17129610
[TBL] [Abstract][Full Text] [Related]
5. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
Maremmani I; Pani PP; Pacini M; Perugi G
J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
[TBL] [Abstract][Full Text] [Related]
6. Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial.
Chawarski MC; Mazlan M; Schottenfeld RS
Drug Alcohol Depend; 2008 Apr; 94(1-3):281-4. PubMed ID: 18164145
[TBL] [Abstract][Full Text] [Related]
7. Patterns of major depression and drug-related problems amongst heroin users across 36 months.
Darke S; Mills K; Teesson M; Ross J; Williamson A; Havard A
Psychiatry Res; 2009 Mar; 166(1):7-14. PubMed ID: 19215987
[TBL] [Abstract][Full Text] [Related]
8. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).
Ross J; Teesson M; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
Drug Alcohol Rev; 2005 Sep; 24(5):411-8. PubMed ID: 16298835
[TBL] [Abstract][Full Text] [Related]
9. Opioid maintenance therapy suppresses alcohol intake in heroin addicts with alcohol dependence: preliminary results of an open randomized study.
Nava F; Manzato E; Leonardi C; Lucchini A
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1867-72. PubMed ID: 18801404
[TBL] [Abstract][Full Text] [Related]
10. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
Duburcq A; Charpak Y; Blin P; Madec L
Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
[TBL] [Abstract][Full Text] [Related]
11. Early experience with Suboxone maintenance therapy in Hungary.
Demetrovics Z; Farkas J; Csorba J; Németh A; Mervó B; Szemelyácz J; Fleischmann E; Kassai-Farkas A; Petke Z; Oroján T; Rózsa S; Rigó P; Funk S; Kapitány M; Kollár A; Rácz J
Neuropsychopharmacol Hung; 2009 Dec; 11(4):249-57. PubMed ID: 20150662
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year.
Soeffing JM; Martin LD; Fingerhood MI; Jasinski DR; Rastegar DA
J Subst Abuse Treat; 2009 Dec; 37(4):426-30. PubMed ID: 19553061
[TBL] [Abstract][Full Text] [Related]
13. Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence.
White J; Bell J; Saunders JB; Williamson P; Makowska M; Farquharson A; Beebe KL
Drug Alcohol Depend; 2009 Jul; 103(1-2):37-43. PubMed ID: 19403243
[TBL] [Abstract][Full Text] [Related]
14. Rapid detoxification of heroin dependence by buprenorphine.
Liu ZM; Cai ZJ; Wang XP; Ge Y; Li CM
Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):112-4. PubMed ID: 10072959
[TBL] [Abstract][Full Text] [Related]
15. Multi-centre observational study of buprenorphine use in 32 Italian drug addiction centres.
Leonardi C; Hanna N; Laurenzi P; Fagetti R;
Drug Alcohol Depend; 2008 Apr; 94(1-3):125-32. PubMed ID: 18162330
[TBL] [Abstract][Full Text] [Related]
16. Clinical profile of responders to buprenorphine as a substitution treatment in heroin addicts: results of a multicenter study of 73 patients.
Poirier MF; Laqueille X; Jalfre V; Willard D; Bourdel MC; Fermanian J; Olié JP
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):267-72. PubMed ID: 14751421
[TBL] [Abstract][Full Text] [Related]
17. Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence.
Kakko J; von Wachenfeldt J; Svanborg KD; Lidström J; Barr CS; Heilig M
Biol Psychiatry; 2008 Jan; 63(2):172-7. PubMed ID: 17850768
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine replacement therapy: a confirmed benefit.
Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
[TBL] [Abstract][Full Text] [Related]
19. Time-limited buprenorphine replacement therapy for opioid dependence: 2-year follow-up outcomes in relation to programme completion and current agonist therapy status.
Kornør H; Waal H; Sandvik L
Drug Alcohol Rev; 2007 Mar; 26(2):135-41. PubMed ID: 17364848
[TBL] [Abstract][Full Text] [Related]
20. Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment.
Schäfer I; Eiroa-Orosa FJ; Verthein U; Dilg C; Haasen C; Reimer J
Psychopathology; 2010; 43(2):88-95. PubMed ID: 20068379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
